Ramos-Nieves, R.;                     Armina-Rodriguez, A.;                     Figueroa-Gispert, M.D.M.;                     Figueroa-Quiñones, G.;                     Ocasio-Malavé, C.;                     Espino, A.M.    
        A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice. Vaccines 2025, 13, 545.
    https://doi.org/10.3390/vaccines13050545
    AMA Style
    
                                Ramos-Nieves R,                                 Armina-Rodriguez A,                                 Figueroa-Gispert MDM,                                 Figueroa-Quiñones G,                                 Ocasio-Malavé C,                                 Espino AM.        
                A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice. Vaccines. 2025; 13(5):545.
        https://doi.org/10.3390/vaccines13050545
    
    Chicago/Turabian Style
    
                                Ramos-Nieves, Riseilly,                                 Albersy Armina-Rodriguez,                                 Maria Del Mar Figueroa-Gispert,                                 Ghalib Figueroa-Quiñones,                                 Carlimar Ocasio-Malavé,                                 and Ana M. Espino.        
                2025. "A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice" Vaccines 13, no. 5: 545.
        https://doi.org/10.3390/vaccines13050545
    
    APA Style
    
                                Ramos-Nieves, R.,                                 Armina-Rodriguez, A.,                                 Figueroa-Gispert, M. D. M.,                                 Figueroa-Quiñones, G.,                                 Ocasio-Malavé, C.,                                 & Espino, A. M.        
        
        (2025). A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice. Vaccines, 13(5), 545.
        https://doi.org/10.3390/vaccines13050545